Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

N/ACompletedNCT03831230

Centre Francois Baclesse250 enrolled

Overview

Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Ovarian Cancer

Interventions

collection of blood, urine, tumor and ascite samplesGENETIC

collection of blood, urine, tumor and ascite samples during ovarian surgery

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient over 18 years old. * Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically proven peritoneum. All FIGO stages are accepted for the study. * Patient to be managed by surgery (laparoscopy and / or laparotomy). Exclusion Criteria: * Pregnant woman * Persons deprived of liberty or guardianship (including curatorship) * History of any other clinically active malignancy in the last 5 years prior to inclusion

Locations (1)

Centre François BACLESSE

Caen, France

Outcomes

Primary Outcomes

Rates of exploitable ex vivo tumor, blood and urine samples for performing predictive tests

Number and quality of tumor, blood and urine samples that can be used to perform predictive tests of the response to treatment

Time frame: Collection of blood, urine, tumor and ascite samples at the time of ovarian surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.